NCT03584087View on ClinicalTrials.gov

Efficacy of Terlipressin Therapy in Acute Variceal Haemorrhage After EVL

PHASE4CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

May 7, 2018

Primary Completion Date

July 31, 2019

Study Completion Date

July 31, 2019

Conditions
Acute Variceal Haemorrhage
Interventions
DRUG

Normal Saline

TG 0 (0Hr)

DRUG

Terlipressin

Duration of Terlipressin after EVL

Trial Locations (1)

160012

Post Graduate Institute of Medical Education and Research, Chandigarh

All Listed Sponsors
lead

Post Graduate Institute of Medical Education and Research, Chandigarh

OTHER

NCT03584087 - Efficacy of Terlipressin Therapy in Acute Variceal Haemorrhage After EVL | Biotech Hunter | Biotech Hunter